NDC 0069-1011
Panzyga
Immune Globulin Intravenous (human)
Panzyga is a Intravenous Solution in the Plasma Derivative category. It is labeled and distributed by Pfizer Laboratories Div Pfizer Inc. The primary component is Human Immunoglobulin G.
| Product ID | 0069-1011_070501cc-8328-4bc3-91c8-8688fba3f982 |
| NDC | 0069-1011 |
| Product Type | Plasma Derivative |
| Proprietary Name | Panzyga |
| Generic Name | Immune Globulin Intravenous (human) |
| Dosage Form | Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2019-08-09 |
| Marketing Category | BLA / BLA |
| Application Number | BLA125587 |
| Labeler Name | Pfizer Laboratories Div Pfizer Inc |
| Substance Name | HUMAN IMMUNOGLOBULIN G |
| Active Ingredient Strength | 100 mg/mL |
| Pharm Classes | Human Immunoglobulin G [EPC],Passively Acquired Immunity [PE],Antigen Neutralization [MoA],Immunoglobulins [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
Packaging
NDC 0069-1011-02
1 BOTTLE, GLASS in 1 CARTON (0069-1011-02) > 10 mL in 1 BOTTLE, GLASS (0069-1011-01)
| Marketing Start Date | 2019-08-09 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 0069-1011-02 [00069101102]
Panzyga SOLUTION
| Marketing Category | BLA |
| Application Number | BLA125587 |
| Product Type | PLASMA DERIVATIVE |
| Billing Unit | ML |
| Marketing Start Date | 2019-08-09 |
NDC 0069-1011-01 [00069101101]
Panzyga SOLUTION
| Marketing Category | BLA |
| Application Number | BLA125587 |
| Product Type | PLASMA DERIVATIVE |
| Billing Unit | ML |
| Marketing Start Date | 2019-08-09 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| HUMAN IMMUNOGLOBULIN G | 100 mg/mL |
Pharmacological Class
- Human Immunoglobulin G [EPC]
- Passively Acquired Immunity [PE]
- Antigen Neutralization [MoA]
- Immunoglobulins [CS]
- Human Immunoglobulin G [EPC]
- Passively Acquired Immunity [PE]
- Antigen Neutralization [MoA]
- Immunoglobulins [CS]
NDC Crossover Matching brand name "Panzyga" or generic name "Immune Globulin Intravenous (human)"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0069-1011 | Panzyga | immune globulin intravenous (human) |
| 0069-1109 | Panzyga | immune globulin intravenous (human) |
| 0069-1224 | Panzyga | immune globulin intravenous (human) |
| 0069-1312 | Panzyga | immune globulin intravenous (human) |
| 0069-1415 | Panzyga | immune globulin intravenous (human) |
| 0069-1558 | Panzyga | immune globulin intravenous (human) |
| 68982-820 | Panzyga | immune globulin intravenous (human) |
| 68982-822 | Panzyga | immune globulin intravenous (human) |
| 61953-0005 | FLEBOGAMMA DIF | IMMUNE GLOBULIN INTRAVENOUS (HUMAN) |
| 0944-2623 | GAMMAGARD | Immune Globulin Intravenous (Human) |
| 0944-2625 | GAMMAGARD | Immune Globulin Intravenous (Human) |
| 0944-2627 | GAMMAGARD | Immune Globulin Intravenous (Human) |
| 0944-2656 | GAMMAGARD | Immune Globulin Intravenous (Human) |
| 0944-2658 | GAMMAGARD | Immune Globulin Intravenous (Human) |
Trademark Results [Panzyga]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 PANZYGA 79148226 4630483 Live/Registered |
Octapharma AG 2014-04-03 |
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.